Health

Health and lifestyle features.

Kenta Biotech vollzieht mit Umzug in den Bio-Technopark Zürich-Schlieren wichtigen strategischen Schritt

Kenta Biotech verlegt ihren Firmensitz von Bern in den Bio-Technopark in Zürich-Schlieren, dem Silicon Valley der Schweizer Biotechnologie.

Kenta Biotech makes strategic move by relocating to Bio-Technopark in Zurich-Schlieren

Kenta Biotech announced today that it is relocating from Bern to Bio-Technopark in Zurich-Schlieren, the Silicon Valley of Swiss Biotechnology.

Kenta Biotech erhält Status der EU für einen humanen monoklonalen Antikörper gegen schwere pneumonien

Kenta Biotech hat heute bekannt gegeben, dass die Europäische Kommission ihrem Produkt KBSA301 den Status eines Medikaments für seltene Krankheiten (Orphan Drug) erteilt hat.

Kenta Biotech obtains EU Orphan Drug Status for antibody against pneumonia

Kenta Biotech announced today that the European Commission has granted 'Orphan Drug' status to Kenta Biotech’s product KBSA301 for the treatment of severe pneumonia caused by Staphylococcus aureus (S. aureus).

Bladder cancer – we know more, but still not enough…

Action on Bladder Cancer (ABC) releases findings from a new National survey* exposing how little the general public knows about bladder cancer.

Chinese entrepreneur to support access to medicines for developing world

HNA Group's Chen Feng is designated UNITAID's Honorary Ambassador.

Unitaid invite instamment la communaute internationale a prendre trois mesure concretes sure preserver les progres de la lutte contre le Sida

Au deuxième jour de la conférence de l’AFRAVIH, conférence francophone internationale sur le sida à Genève, UNITAID appelle la communauté internationale à prendre trois mesures urgentes pour surmonter les obstacles entravant les progrès de la lutte contre le sida : réduire l’effet des accords de libre-échange,  puiser dans de nouvelles sources de financement, comme une taxe sur les transactions financières, et promouvoir des traitements optimisés et abordables en agissant au niveau des marchés. 

Unitaid urges global community to enact three concrete measures to salvage progress against AIDS

On the second day of AFRAVIH, a Francophone international AIDS  conference in Geneva, UNITAID calls on the international community to implement three urgent measures to overcome obstacles in the progress against AIDS: reduce the effect of free trade agreements, tap into fresh sources of funding, such as a financial transaction tax, and promote treatment optimization and affordability through market approaches. 

Unitaid Warns Against Measures to Restrict Access to Medicines in EU-India FTA

In the lead up to Free Trade Agreement (FTA) discussions during the European Union-India Summit in New Delhi on 10 February, UNITAID urges both parties to ensure that access to medicines, and particularly AIDS medicines,is not hampered by trade interests via provisions that could undermine the production, registration and availability of generic medicines. 

UNITAID CONTINUES FUNDING FOR MEDICINES PATENT POOL AND PAEDIATRIC AIDS MEDICINES - Additional US$ 50 Million Allotted to Malaria

At its meeting in Paris on 12-13 December, the UNITAID Executive Board demonstrated its continued commitment to scaling up access for HIV/AIDS and malaria by allocating an extra US$ 138 million to the two diseases.

Pages

Subscribe to RSS - Health